47 entries
5-Amino-1MQ
- Class
- NNMT inhibitor (small molecule)
- Half-life
- ~hours
- Mechanism
- Inhibits nicotinamide N-methyltransferase, raising NAD+ pools.
ARA-290
Cibinetide
- Class
- Erythropoietin-derived 11-mer peptide
- Half-life
- ~2 min (systemic)
- Mechanism
- Activates the innate repair receptor (IRR/βcR–EpoR heteromer) without erythropoiesis.
Available sizes
BPC-157
- Class
- Synthetic pentadecapeptide (gastric origin)
- Half-life
- ~30–60 min (systemic)
- Mechanism
- Modulates nitric oxide and VEGF pathways supporting angiogenesis.
Cagrilintide
- Class
- Long-acting amylin analogue
- Half-life
- ~7 days
- Mechanism
- Activates amylin/calcitonin receptors.
Cerebrolysin
- Class
- Neurotrophic peptide mixture
- Half-life
- Variable
- Mechanism
- Mimics endogenous neurotrophic factor action.
CJC-1295 (no DAC)
Mod GRF (1-29)
- Class
- GHRH analogue
- Half-life
- ~30 min
- Mechanism
- Stimulates anterior pituitary GHRH receptors for short GH pulses.
CJC-1295 with DAC
- Class
- Long-acting GHRH analogue
- Half-life
- ~6–8 days
- Mechanism
- Drug Affinity Complex binds albumin for sustained GHRH signaling.
Dihexa
- Class
- Angiotensin IV analogue
- Half-life
- Several hours
- Mechanism
- Hepatocyte growth factor / c-Met augmentation.
DSIP
Delta Sleep-Inducing Peptide
- Class
- Nonapeptide
- Half-life
- ~7 min (systemic)
- Mechanism
- Modulates EEG delta-wave activity and stress-response peptide release.
Epitalon
- Class
- Tetrapeptide (Ala-Glu-Asp-Gly)
- Half-life
- Short
- Mechanism
- Reported telomerase modulation in cell models.
FOXO4-DRI
- Class
- Retro-inverso peptide
- Half-life
- Short
- Mechanism
- Disrupts FOXO4–p53 interaction in senescent cells.
Available sizes
GHK-Cu
- Class
- Copper-binding tripeptide
- Half-life
- Short (minutes systemic)
- Mechanism
- Copper chaperone modulating ECM and antioxidant gene expression.
GHRP-2
- Class
- Hexapeptide GH secretagogue (ghrelin mimetic)
- Half-life
- ~15–60 min
- Mechanism
- GHS-R1a agonist driving GH release with modest cortisol/prolactin activity.
Available sizes
GHRP-6
- Class
- Hexapeptide GH secretagogue (ghrelin mimetic)
- Half-life
- ~15–60 min
- Mechanism
- GHS-R1a agonist; notable appetite-stimulating activity via ghrelin pathway.
Glutathione
GSH
- Class
- Tripeptide antioxidant (Glu-Cys-Gly)
- Half-life
- ~10 min (plasma)
- Mechanism
- Primary intracellular thiol antioxidant; cofactor for GPx, GST enzyme families.
HCG
Human Chorionic Gonadotropin
- Class
- Glycoprotein hormone (LH-receptor agonist)
- Half-life
- ~24–36 h
- Mechanism
- Binds LH/CG receptors to drive gonadal steroidogenesis.
Hexarelin
- Class
- GH secretagogue
- Half-life
- ~55 min
- Mechanism
- Potent ghrelin receptor agonist with cardiac receptor activity.
Humanin
- Class
- 24-aa mitochondrial-derived peptide
- Half-life
- Short
- Mechanism
- Cytoprotective via STAT3 and IGFBP-3 binding.
IGF-1 LR3
- Class
- Long-Arg3 IGF-1 analogue
- Half-life
- ~20–30 h
- Mechanism
- Reduced binding to IGFBPs prolongs free fraction.
Available sizes
Ipamorelin
- Class
- Selective GH secretagogue (ghrelin mimetic)
- Half-life
- ~2 h
- Mechanism
- Selective GHS-R1a agonist driving pulsatile GH release without cortisol/prolactin elevation.
Kisspeptin-10
- Class
- GPR54/KISS1R agonist decapeptide
- Half-life
- ~4 min
- Mechanism
- Activates KISS1R on GnRH neurons to drive LH/FSH release.
Available sizes
KPV
- Class
- α-MSH C-terminal tripeptide
- Half-life
- Short
- Mechanism
- Anti-inflammatory action via melanocortin pathway.
Available sizes
Liraglutide
- Class
- GLP-1 receptor agonist
- Half-life
- ~13 h
- Mechanism
- Acylated GLP-1 analogue with albumin binding for extended action.
LL-37
- Class
- Cathelicidin antimicrobial peptide
- Half-life
- Short
- Mechanism
- Disrupts microbial membranes; modulates innate immunity.
Available sizes
Mazdutide
- Class
- GLP-1/Glucagon dual agonist
- Half-life
- ~5 days
- Mechanism
- Co-activation of GLP-1 and glucagon receptors for incretin/hepatic crosstalk.
Melanotan 1
Afamelanotide
- Class
- Linear α-MSH analogue
- Half-life
- ~30 min (free); depot forms much longer
- Mechanism
- Selective MC1R-biased melanocortin agonist driving eumelanin synthesis.
Available sizes
Melanotan II
- Class
- Cyclic α-MSH analogue
- Half-life
- ~2 h
- Mechanism
- Non-selective melanocortin receptor agonist (MC1R/MC3R/MC4R).
Available sizes
MK-677
Ibutamoren
- Class
- Oral ghrelin mimetic (non-peptide)
- Half-life
- ~24 h
- Mechanism
- Orally bioavailable GHS-R agonist.
MOTS-c
- Class
- Mitochondrial-derived peptide (16 aa)
- Half-life
- Short
- Mechanism
- Activates AMPK and modulates folate/methionine cycle.
NAD+
Nicotinamide Adenine Dinucleotide
- Class
- Pyridine nucleotide coenzyme
- Half-life
- Variable (rapid extracellular turnover)
- Mechanism
- Essential coenzyme for redox reactions, sirtuin and PARP enzyme families.
Oxytocin
- Class
- Cyclic nonapeptide hormone
- Half-life
- ~3–5 min
- Mechanism
- Agonist at the oxytocin receptor (OXTR); CNS and peripheral signaling.
Pinealon
- Class
- Tripeptide (Glu-Asp-Arg)
- Half-life
- Short
- Mechanism
- Penetrates BBB; modulates oxidative stress markers.
Available sizes
PT-141
Bremelanotide
- Class
- Selective MC4R agonist
- Half-life
- ~2 h
- Mechanism
- Central melanocortin pathway modulation.
Available sizes
Retatrutide
- Class
- Triple GIP/GLP-1/Glucagon agonist
- Half-life
- ~6 days
- Mechanism
- Simultaneous activation of three incretin/glucagon receptors.
Selank
- Class
- Tuftsin analogue
- Half-life
- Short
- Mechanism
- Modulates GABAergic tone and enkephalin metabolism.
Available sizes
Semaglutide
Ozempic, Wegovy (reference)
- Class
- GLP-1 receptor agonist
- Half-life
- ~165 h (7 days)
- Mechanism
- Selective agonism of the GLP-1 receptor modulating insulin secretion and gastric emptying.
Semax
- Class
- ACTH(4-10) analogue (heptapeptide)
- Half-life
- Short (intranasal)
- Mechanism
- Modulates BDNF and dopamine/serotonin signaling.
Available sizes
Sermorelin
- Class
- GHRH (1-29) analogue
- Half-life
- ~10–20 min
- Mechanism
- Native GHRH fragment stimulating pituitary GH release.
Snap-8
Acetyl Octapeptide-3
- Class
- SNAP-25 mimetic octapeptide
- Half-life
- Topical — N/A systemic
- Mechanism
- Competes with SNAP-25 in the SNARE complex to modulate vesicle docking.
Available sizes
SS-31
Elamipretide
- Class
- Mitochondria-targeted tetrapeptide
- Half-life
- ~2 h
- Mechanism
- Binds cardiolipin to stabilize inner mitochondrial membrane.
Survodutide
- Class
- Glucagon/GLP-1 dual agonist
- Half-life
- ~5 days
- Mechanism
- Balanced glucagon and GLP-1 receptor activation.
Available sizes
TB-500
Thymosin Beta-4 fragment
- Class
- Actin-sequestering peptide
- Half-life
- ~2–3 h
- Mechanism
- Promotes cell migration, angiogenesis and actin remodeling.
Tesamorelin
- Class
- Stabilized GHRH analogue
- Half-life
- ~25–40 min
- Mechanism
- Trans-3-hexenoic acid N-terminal modification for proteolytic resistance.
Thymalin
- Class
- Thymic peptide complex
- Half-life
- Short
- Mechanism
- Modulates T-cell differentiation markers.
Thymosin Alpha-1
Tα1
- Class
- 28-aa thymic peptide
- Half-life
- ~2 h
- Mechanism
- TLR-mediated dendritic cell activation.
Tirzepatide
Mounjaro (reference)
- Class
- Dual GIP/GLP-1 receptor agonist
- Half-life
- ~120 h (5 days)
- Mechanism
- Co-activation of GIP and GLP-1 receptors for incretin pathway studies.
VIP
Vasoactive Intestinal Peptide
- Class
- 28-aa secretin-family peptide
- Half-life
- ~2 min (plasma)
- Mechanism
- Agonist at VPAC1/VPAC2 receptors; broad immunomodulatory and vasodilator activity.
Available sizes
Marbella & Costa del Sol
Regena Peptides is based on the Costa del Sol and supplies research-grade compounds to laboratories and independent researchers across Marbella, Puerto Banús, Nueva Andalucía, San Pedro de Alcántara, Estepona, Benahavís, Mijas, Fuengirola, Sotogrande, Málaga city and the wider Andalucía region.
Research-Use Disclaimer
All information is provided for educational and scientific reference purposes only. The compounds listed are research chemicals intended for in-vitro investigation by qualified professionals. Nothing on this page constitutes medical advice, a therapeutic claim, or dosing guidance.